insights into the safety and efficacy of belantamab mafodotin in systemic al amyloidosis
Published 4 weeks ago • 27 plays • Length 2:16Download video MP4
Download video MP3
Similar videos
-
1:52
safety and efficacy of idasanutlin in pv
-
3:29
belantamab mafodotin in myeloma: advantages and disadvantages
-
4:48
an insight into the management of cytopenias in mf
-
2:56
insights into the healthtree foundation
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
2:01
belantamab mafodotin in r/r myeloma and methods of reducing ocular toxicity
-
1:38
insightec blood brain barrier (bbb) disruption
-
5:11
how to get visibility of your true attack surface
-
1:17
novel treatment approaches being explored in amyloidosis: immunotherapeutic agents & venetoclax
-
2:26
an insight into the aims of the eurasian hematology-oncology group
-
0:47
unmet needs in amyloidosis treatment in the uk
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy
-
2:08
an insight into the current understanding of risk factors for cll
-
4:28
heterogeneity in treatment preferences of patients with r/r multiple myeloma
-
3:54
an insight into how novel agents are influencing survival outcomes in patients with mf
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
2:31
integrating bcma-targeted agents in earlier lines of therapy for r/r multiple myeloma
-
2:42
results from majestec-1: health-related quality of life with teclistamab in patients with r/r mm
-
2:14
risk-adapted treatment of et & pv